Clinical Research Directory
Browse clinical research sites, groups, and studies.
"Sexual Health Assessment of TinidaZole Against M. Genitalium (SHAZAM)"
Sponsor: University of Washington
Summary
The objective is to estimate the efficacy of tinidazole for the treatment of Mycoplasma genitalium (MG) among male patients who have been diagnosed with non-gonococcal urethritis (NGU) at the Public Health - Seattle \&King County (PHSKC) Sexual Health Clinic (SHC). Tinidazole was approved by the Food and Drug Administration (FDA) in May 2004 to treat other infections (i.e., trichomoniasis, giardiasis, amebiasis, bacterial vaginosis) but has not been systematically tested for effectiveness against M. genitalium. The dosing that the investigators are proposing does not significantly increase the risk associated with taking tinidazole and this investigation meets criteria for an IND exemption.
Official title: Tinidazole for Mycoplasma Genitalium-Urethritis in the Public Health - Seattle & King County Sexual Health Clinic
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2025-07-23
Completion Date
2026-08-31
Last Updated
2025-07-30
Healthy Volunteers
No
Interventions
Tinidazole
2 grams orally on day one followed by 500mg orally twice daily on days 2-10
Locations (1)
Harborview Medical Center, Public Health - Seattle & King County Sexual Health Clinic
Seattle, Washington, United States